Parmax Pharma Ltd — Quarterly Results & Earnings

₹28.44

-9.12%

Profit Growth YoY-845.45%Latest quarter

Sales Growth YoY-72.74%Latest quarter

Sales CAGR 5Y6.15%5 year compound

Profit CAGR 5YN/A5 year compound

📋

Quarterly Performance

YoY Profit Growth-845.45%

🔴 Significant decline

YoY Sales Growth-72.74%

🔴 Significant decline

OPM 5Y Average

Operating profit margin

5.19%

EPS Growth 5Y

N/A

Interest Coverage

Higher = safer debt servicing

-3.55

ROE

N/A

ROCE

-12.45%

💡

Growth Analysis

Parmax Pharma Ltd reported YoY profit growth of -845.45% and revenue growth of -72.74% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at 6.15% and profits at N/A annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Parmax Pharma Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.